Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients

Por Gabasa, M, Ikemori, R, Hilberg, F, Reguart, N, Alcaraz, J
Publicado no Br J Cancer (2017)

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

Por Majem, M., Juan, O., Insa, A., Reguart, N., Trigo, J. M., Carcereny, E., García-Campelo, R., García, Y., Guirado, M., Provencio, M.
Publicado no Clin Transl Oncol (2018)